1. Home
  2. RPRX vs MAIR Comparison

RPRX vs MAIR Comparison

Compare RPRX & MAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$57.16

Market Cap

22.0B

Sector

Health Care

ML Signal

HOLD

Logo Madison Air Solutions Corporation Class A Common Stock

MAIR

Madison Air Solutions Corporation Class A Common Stock

N/A

Current Price

$36.86

Market Cap

19.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RPRX
MAIR
Founded
1996
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Pollution Control Equipment
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.0B
19.1B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
RPRX
MAIR
Price
$57.16
$36.86
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$51.40
N/A
AVG Volume (30 Days)
3.5M
2.3M
Earning Date
05-06-2026
N/A
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
0.67
N/A
Revenue
$2,378,193,000.00
N/A
Revenue This Year
$38.63
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
$86.22
N/A
Revenue Growth
5.06
N/A
52 Week Low
$34.63
$36.02
52 Week High
$57.79
$41.89

Technical Indicators

Market Signals
Indicator
RPRX
MAIR
Relative Strength Index (RSI) 63.95 42.28
Support Level $38.07 N/A
Resistance Level N/A $41.89
Average True Range (ATR) 1.50 1.92
MACD 0.16 -0.13
Stochastic Oscillator 99.55 19.76

Price Performance

Historical Comparison
RPRX
MAIR

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About MAIR Madison Air Solutions Corporation Class A Common Stock

Madison Air Solutions Corp is an HVAC and indoor air-quality technology company. Its segments are Commercial and Residential. It generates the majority of its revenue from the Commercial segment, which includes Commercial businesses that deliver well-engineered, custom, and semi-custom air quality systems to support process control, regulatory compliance, energy efficiency, and productivity in mission-critical environments; and the Residential segment, anchored by trusted brands like AprilAire, Broan-NuTone, Zephyr, and Others. Its geographic areas are the U.S, the Americas, Europe, and Other. The group generates the majority of its revenue from the U.S market.

Share on Social Networks: